The Oncology, Hematology and NUclear Medicine Graduate Programme is established in Nantes. It is accessible to students at master's and doctoral levels.
The programme combines three disciplines to meet the challenge of understanding, detecting and treating cancers. This requires a
multi-scale (from a single cell to the whole body) and
interdisciplinary approach (oncology, immunology, targeted therapies, bioinformatics analysis). Moreover, it addresses all aspects of
tumour ecosystem development in different types of cancers (solid and hematological malignancies) and the specific problems of medical imaging that stimulating and
mapping tumours non-invasively - a multi-scale cellular approach of
multimodal full body imaging (PET-MRI, innovative radiopharmaceuticals...)
The GP approaches therapeutic challenges, including innovative therapies such as targeted therapies, immunotherapies and therapeutic nuclear medicine and theranostic approaches in multiple solid and hematological tumours.
Why joining the Oncology, Hematology and Nuclear Medicine Graduate Programme (OHNU)?
Our Graduate Programmes are trainings by and through elemental and translational research.
GP OHNU scientific areas:
- Immunomodulation of the tumour microenvironment and immunotherapy of cancers
- Nuclear oncology
- Signalling in oncogenesis, angiogenesis and permeability
- Adaptation to stress and tumour escape
- Integrated cancer genomics
- Chromatin and transcriptional deregulation in paediatric bone sarcoma
- Plasticity of the tumour ecosystem after radiotherapy
- Molecular vulnerabilities of tumour escape in mature Bcell malignancies
- Lymphocyte manipulation for immunotherapy